PART A: Efficacy and Safety of AEVI-001 in Children and Adolescents With ADHD and With mGluR Mutations
Clinical trial NCT03265119 · COMPLETED
Trial details
- NCT number
- NCT03265119
- Sponsor
- Aevi Genomic Medicine, LLC, a Cerecor company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-28
- Primary completion
- 2018-09-24
- Enrollment
- 69
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.